NasdaqCM - Nasdaq Real Time Price USD
Tvardi Therapeutics, Inc. (TVRD)
18.61
+0.21
+(1.14%)
As of 12:10:11 PM EDT. Market Open.
Breakdown
12/31/2023
12/31/2022
Total Assets
27,001
45,097
Total Liabilities Net Minority Interest
89,059
90,148
Total Equity Gross Minority Interest
-62,058
-45,051
Total Capitalization
-62,058
-45,051
Common Stock Equity
-62,058
-45,051
Capital Lease Obligations
368
450
Net Tangible Assets
-62,506
-45,562
Working Capital
22,877
39,832
Invested Capital
-62,058
-45,051
Tangible Book Value
-62,506
-45,562
Total Debt
368
450
Share Issued
9,355.54
9,355.54
Ordinary Shares Number
9,355.54
9,355.54
12/31/2022 - 1/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMRX Immuneering Corporation
1.4700
+4.26%
INZY Inozyme Pharma, Inc.
0.9697
-1.11%
SXTP 60 Degrees Pharmaceuticals, Inc.
3.3900
+12.62%
MAZE Maze Therapeutics, Inc.
8.93
-6.49%
AKTX Akari Therapeutics, Plc
1.4499
-0.01%
PVLA Palvella Therapeutics, Inc.
26.99
+1.62%
BCAX Bicara Therapeutics Inc.
15.31
-1.29%
RZLT Rezolute, Inc.
3.9700
0.00%
MLEC Moolec Science SA
0.6190
+6.72%
KZIA Kazia Therapeutics Limited
3.2400
-1.82%